Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Frailty × epigallocatechin gallate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 4 Papillomavirus Infections 2 Triple Negative Breast Neoplasms 1 Radiodermatitis 1 Prostatic Neoplasms 1 Papilloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Inflammation 1 Frailty 1 Fibrosis 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Geriatric Assessment 9 Preoperative Exercise 2 Nutritional Support 2 Exercise 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 diacetamate 1 cabozantinib 1 Tretinoin 1 Therapeutics 1 Temozolomide 1 Standard of Care 1 Restraint, Physical 1 Quercetin 1 Qigong 1 Psychosocial Intervention 1 Protons 1 Photons 1 Nutrition Assessment 1 Methods 1 Immunonutrition Diet 1 Flavonoids 1 Enhanced Recovery After Surgery 1 Dasatinib 1 Control Groups 1 Capecitabine 1 Azacitidine 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡